In a mouse myeloma model with bone lesions generated by transplanting a human myeloma cell line into NOD-SCID mice, elevated blood levels of human DKK1 were observed, and while human sclerostin level was undetected, mouse sclerostin level was elevated. This evidence concerns the gene SOST and plasma cell myeloma.